Clinical Development of Minimally-Invasive Bioassays to Support Outpatient Clinical Trials of Therapeutics for Substance Use Disorders
Published Date
Agency
CFDA
93.279
Contact Information
National Institutes of Health Grants Information, 301-435-0714; GrantsInfo@nih.gov
Deadline
Department
Eligiblity
State, tribal and local governments, institutions of higher education, public housing authorities, nonprofits and for-profits
More Information
Program Area
Programe Purpose
To support research that develops outpatient clinical trials involving pharmaceutical drugs to treat substance use disorders
